Pharmacokinetics of liquiritigenin in mice, rats, rabbits, and dogs, and animal scale-up.

Pharmacokinetics of liquiritigenin (LQ) and its two glucuronide metabolites, M1 and M2, in mice, rats, rabbits, and dogs and animal scale-up of the pharmacokinetic parameters of LQ were evaluated. After intravenous administration of LQ, the AUC (AUC(0-t)) values of LQ, M1, and M2 were proportional to LQ doses in all animals studied. Animal scale-up of some pharmacokinetic parameters of LQ was performed based on the parameters after its intravenous administration (20 mg/kg; in the linear pharmacokinetic range) to the four species. Linear relationships were obtained (r > 0.968) between log CL (or CL/f(u)) (L/h) and log species body weight (W) (kg) [CL (or CL/f(u)) = 3.29 (34.0) W(0.723 (0.789))] and log V(ss) (or V(ss)/f(u)) (L) and log W (kg) [V(ss) (or V(ss)/f(u)) = 0.340 (3.52) W(0.882 (0.948))]. Interspecies scale-up of plasma concentration-time data of LQ using apolysichron (complex Dedrick plots) resulted in similar profiles, and plasma concentration-time profile of humans were predicted using the well-fitted four animal data. Our results indicate that the LQ data obtained from laboratory animals could be utilized to generate preliminary estimates of the pharmacokinetic parameters of LQ in humans. These parameters can serve as guidelines for better planning of clinical studies.

[1]  E. Adolph,et al.  Quantitative Relations in the Physiological Constitutions of Mammals. , 1949, Science.

[2]  H. Shimamura,et al.  Biliary and Urinary Metabolites of Liquiritin in Rats , 1990 .

[3]  Young Woo Kim,et al.  Liquiritigenin, an aglycone of liquiritin in Glycyrrhizae radix, prevents acute liver injuries in rats induced by acetaminophen with or without buthionine sulfoximine. , 2006, Chemico-biological interactions.

[4]  W. Jusko,et al.  Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. , 1984, Journal of pharmaceutical sciences.

[5]  Kang Hee Eun,et al.  Determination of an Agent for the Inflammatory Liver Disease, Liquiritigenin, in Rat Plasma, Urine, and Various Tissue Homogenates by High-performance Liquid Chromatography , 2008 .

[6]  W. L. Chiou,et al.  Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[7]  Y. Sugiyama,et al.  Identification of tissues responsible for the conjugative metabolism of liquiritigenin in rats: an analysis based on metabolite kinetics. , 1993, Biological & pharmaceutical bulletin.

[8]  L. Whitfield,et al.  Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humans. , 1990, Cancer research.

[9]  Y. Sugiyama,et al.  Multiple systems for the biliary excretion of organic anions in rats: liquiritigenin conjugates as model compounds. , 1994, The Journal of pharmacology and experimental therapeutics.

[10]  Tim Morris,et al.  Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.

[11]  Robert L. Dedrick,et al.  Animal scale-up , 1973, Journal of Pharmacokinetics and Biopharmaceutics.

[12]  T. Guentert,et al.  Comparison of Equilibrium Times in Dialysis Experiments Using Spiked Plasma or Spiked Buffer , 1982 .

[13]  S. Riegelman,et al.  Complications in using rabbits for the study of oral drug absorption. , 1969, Chemical & pharmaceutical bulletin.

[14]  Y. Choi,et al.  Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition , 1993, Journal of Pharmacokinetics and Biopharmaceutics.

[15]  Myung G. Lee,et al.  Effects of leucovorin on the pharmacokinetics of methotrexate in rabbits , 1992 .

[16]  T. Izumi,et al.  Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach. , 1996, The Journal of pharmacology and experimental therapeutics.

[17]  C. Klaassen,et al.  Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[18]  J. Kwon,et al.  Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA-8159, using an equilibrium dialysis technique. , 2000, Biopharmaceutics & drug disposition.

[19]  J. Mordenti,et al.  Man versus beast: pharmacokinetic scaling in mammals. , 1986, Journal of pharmaceutical sciences.

[20]  K. Bischoff,et al.  Interspecies correlation of plasma concentration history of methotrexate (NSC-740). , 1970, Cancer chemotherapy reports.

[21]  H Boxenbaum,et al.  Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. , 1984, Drug metabolism reviews.

[22]  So H. Kim,et al.  Interspecies pharmacokinetic scaling of DA‐8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics , 2005, Biopharmaceutics & drug disposition.

[23]  Y. Sugiyama,et al.  Prediction of ACNU plasma concentration-time profiles in humans by animal scale-up , 2004, Cancer Chemotherapy and Pharmacology.

[24]  M. Gibaldi,et al.  Pharmacokinetics, Second Edition , 1982 .

[25]  A. Kurihara,et al.  Prediction of pharmacokinetics of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, in humans using animal data. , 2007, Xenobiotica; the fate of foreign compounds in biological systems.

[26]  C. Yang,et al.  Cytoprotective effects of Glycyrrhizae radix extract and its active component liquiritigenin against cadmium-induced toxicity (effects on bad translocation and cytochrome c-mediated PARP cleavage). , 2004, Toxicology.

[27]  H. Boxenbaum,et al.  Interspecies pharmacokinetic scaling and the Dedrick plots. , 1983, The American journal of physiology.